Phase II Study of Intravesical Therapy With AD32 in Patients With Papillary Urothelial Carcinoma or Carcinoma in Situ (CIS) Refractory to Prior Therapy With Bacillus Calmette-Guerin (E3897): A Trial of the Eastern Cooperative Oncology Group
Urologic Oncology: Seminars and Original Investigations - United States
doi 10.1016/j.urolonc.2008.05.004
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2009
Authors
Publisher
Elsevier BV